MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma

Elisa Lappi-Blanco (Oulu, Finland), Elisa Lappi-Blanco, Johanna Mäkinen, Kirsi Laitakari, Shirley Johnson, Riitta Mäkitaro, Risto Bloigu, Siri Lehtonen, Timo Väisänen, Riitta Kaarteenaho

Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Session: Biomarkers, immunology and molecular pathology of lung cancer
Session type: Poster Discussion
Number: 534
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Elisa Lappi-Blanco (Oulu, Finland), Elisa Lappi-Blanco, Johanna Mäkinen, Kirsi Laitakari, Shirley Johnson, Riitta Mäkitaro, Risto Bloigu, Siri Lehtonen, Timo Väisänen, Riitta Kaarteenaho. MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma. Eur Respir J 2015; 46: Suppl. 59, 534

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Is there a difference in the incidence of metastasis at diagnosis of lung cancer between smokers and non smokers?
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Prognostic relevance of histological subtypes in lung cancer – Survival in frequent and rare entities
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013

Serum osteopontin as a prognostic marker in patients with lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Clinical features and prognosis of multiple primary malignancies in patients with lung cancer
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Prognostic factors in non-small cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Prevalence of molecular changes in resected pulmonary adenocarcinomas
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


Methylation of p16 in EBUS-TBNA samples as a predictor of advanced disease in lung cancer
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013

Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor?
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016


Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Impact of persistence of smoking on recurrence after early stage lung surgery
Source: International Congress 2016 – Smoking-related diseases
Year: 2016